The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine

About this update from Precision Peptide Company Inc

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that its needle-free Recovery Patch, formulated with BPC-157 peptide, will be featured in the June-August 2026 issue of Men's Health magazine. The placement appears in the magazine's "Going Strong" product showcase, alongside a curated selection of premium men's health, performance, and longevity products. Men's Health is one of the largest mainstream consumer health publications in North America, reaching a broad readership across the performance, recovery, and lifestyle wellness audience. The feature marks the Company's first appearance in a major mainstream U.S. consumer health title and reflects the broader cultural shift bringing peptide-based wellness into the consideration set of everyday consumers. The placement directs readers to precisionpeptidecompany.com, where the Recovery Patch and the Company's wider Amino Innovations product line are available. The Recovery Patch contains one of the most widely discussed peptides in the recovery and performance space – BPC-157 (Body Protection Compound-157) – into a single wearable, transdermal format. Worn directly on the skin and precision-engineered for controlled, sustained delivery, the patch removes the reconstitution, sterile handling, and dose measurement associated with injectable peptide therapies, opening up peptide-based recovery accessible to a wider consumer audience. Pratap Sandhu, CEO of The Precision Peptide Company, commented: "Appearing in Men's Health is a meaningful moment for the Company and, we believe, for the category as a whole. We built the Recovery Patch around the conviction that peptides belong in mainstream consumer wellness – not just in biohacking communities or clinical settings – and the magazine's readership is exactly the audience we developed this product to serve. We see this feature as an early signal of the broader consumer conversation that needle-free peptide delivery is now ready to have." The Men's Health feature follows a period of accelerating momentum at the Company, including the release of Chief Scientific Officer Justin Kirkland's appearance on The Human Upgrade with Dave Asprey, the Company's recentl...

View stock analysis, news, and events for Precision Peptide Company Inc